-
De-siloing substance misuse and self-harm research through integrated public health and emergency medicine Lancet Public Health (IF 25.4) Pub Date : 2025-05-15 Lisa Schölin, Chris Humphries, Michael Eddleston, Gearóid Brennan, Adam Lloyd, Matthew J Reed, Michael E Bryan, Linda J Smith, Jonathan Brett
Acute and chronic problems related to alcohol, drugs, and self-harm are important public health challenges and are compounded by socioeconomic inequalities. People with substance use disorders or mental ill health, or both, are attended to by ambulance and emergency departments at higher rates than the general population and their outcomes are often poor, with mortality ranging from 5% to 15% within
-
Potassium-enriched salt: a new era for UK salt reduction? Lancet Public Health (IF 25.4) Pub Date : 2025-05-12 Elisa Pineda, Thomas E Beaney
WHO's new guideline advocating for the switch from regular salt (sodium chloride) to potassium-enriched salt substitutes marks a transformative step in global efforts to reduce hypertension, stroke, and cardiovascular disease.1 Despite pioneering salt reduction strategies since the early 2000s, the UK faces a stagnation in progress.2, 3 The new guideline should provide a renewed impetus for a stronger
-
Medical conditions and the risk of subsequent major depressive disorder: a nationwide, register-based, retrospective cohort study Lancet Public Health (IF 25.4) Pub Date : 2025-05-09 Per E Sigvardsen, Emil Fosbøl, Anders Jørgensen, Christian Torp-Pedersen, Lars Køber, Klaus F Kofoed
BackgroundMajor depressive disorder can develop subsequent to medical conditions; however, it is unknown if some individuals are at higher risk than others. We aimed to provide comprehensive estimates for the risk of major depressive disorder subsequent to the onset of various medical conditions. MethodsIn this nationwide, population-based, retrospective cohort study, individuals living in Denmark
-
Risk of depressive disorder after a range of medical conditions: the importance of registers Lancet Public Health (IF 25.4) Pub Date : 2025-05-09 Oleguer Plana-Ripoll, Natalie C Momen
The interplay between major depressive disorder and other medical conditions is complex and likely bidirectional.1 With the use of electronic administrative registers, it is possible to comprehensively investigate associations between different comorbid conditions. This type of data often includes routinely collected information on an entire population, allowing researchers to consider such associations
-
Correction to Lancet Public Health 2025; 10: e391–400 Lancet Public Health (IF 25.4) Pub Date : 2025-04-30
Li A, Leppold C. Long-term mental health trajectories across multiple exposures to climate disasters in Australia: a population-based cohort study. Lancet Public Health 2025; 10: e391–400—In table 2 of this Article, the text in the far left column for the subcategories below Second disaster and Third disaster should have read “vs before disaster one”. This correction has been made as of April 30, 2025
-
Reviving action on child health—now! Lancet Public Health (IF 25.4) Pub Date : 2025-04-29 The Lancet Public Health
Halving under-5 mortality within a generation has been the most spectacular success in health during modern times. The child survival movement of the Millennium Development Goal era (2000–15) unlocked levels of political commitment and new investment never before seen in women's and children's health. Why? Because a remarkable coalition was built between civil society, scientists, policy makers, and
-
Cigarette taxation reduces inequalities in child mortality Lancet Public Health (IF 25.4) Pub Date : 2025-04-29 Garima Bhatt, Kamran Siddiqi
In The Lancet Public Health, Olivia Bannon and colleagues1 provide empirical data to show the distinctive advantage of tobacco taxes in saving children's lives and reducing health inequalities. The authors found that substantial tax increases on cigarettes reduce mortality in children younger than 5 years (hereafter referred to as under-5 mortality), with the poorest quintile benefiting the most. However
-
Climate disasters and mental health: directions for research, practice, and policy Lancet Public Health (IF 25.4) Pub Date : 2025-04-29 Sarah R Lowe, Dana Rose Garfin
Climate change has increased the frequency, severity, and lethality of climate disasters, including hurricanes, wildfires, and floods, with these trends expected to escalate.1 Resultingly, individuals and communities will be at increased risk of exposure to multiple disasters over time. Since robust research has correlated disaster exposure with mental ill health,2, 3 understanding how successive disasters
-
Economic costs of neurological and mental health care: implications for research and policy action Lancet Public Health (IF 25.4) Pub Date : 2025-04-29 Crick Lund, Donela Besada
No Abstract
-
Screen no matter the risk? Lancet Public Health (IF 25.4) Pub Date : 2025-04-29 Frerik Smit, Axelle Braggion, Arnaud Chiolero
The systematic review by Naomi Tan and colleagues published in The Lancet Public Health (February issue) on the perceptions of personalised risk-based cancer screening reflects a growing trend in the field, with a risk-based approach seemingly being the future of cancer screening.1 In an era of personalised medicine and precision public health, there is considerable appeal in tailoring cancer screening
-
Cigarette taxation and socioeconomic inequalities in under-5 mortality across 94 low-income and middle-income countries: a longitudinal ecological study Lancet Public Health (IF 25.4) Pub Date : 2025-04-29 Olivia S Bannon MMSc, Jasper V Been PhD, Sam Harper PhD, Anthony A Laverty PhD, Prof Christopher Millett PhD, Prof Frank J van Lenthe PhD, Filippos T Filippidis PhD, Márta K Radó PhD
Although increasing cigarette taxes is known to improve child survival, there are few data on their effect on socioeconomic inequalities in child mortality. We investigated the association between cigarette taxation and socioeconomic inequalities in mortality in children younger than 5 years (hereafter referred to as under-5 mortality) in low-income and middle-income countries (LMICs).
-
Long-term mental health trajectories across multiple exposures to climate disasters in Australia: a population-based cohort study Lancet Public Health (IF 25.4) Pub Date : 2025-04-29 Ang Li PhD, Claire Leppold PhD
Tracking populations through increasingly frequent climate disasters and understanding what contributes to mental health risks is crucial for adaption and planning for a climate changed world. We aimed to examine mental health trajectories after consecutive climate-related disasters and assess differences in mental health outcomes by temporal proximity to previous disasters and risk profiles.
-
Estimating global direct health-care spending on neurological and mental health between 2000 and 2019: a modelling study Lancet Public Health (IF 25.4) Pub Date : 2025-04-29 A J Mitchell PhD, Ian E Cogswell BS, Jeremy Dalos MS, Golsum Tsakalos MS, Jiali Lei MTM, Andrei Oros MA, Quinn Rafferty MS, Serena Santoni BA, Xaviera Steele BS, Joseph L Dieleman PhD, Angela E Apeagyei PhD
The burden of brain disorders, including neurological and mental health conditions, is rising globally. Despite the increasing burden, literature quantifying global spending patterns on care services for brain disorders is sparse. Our aim was to quantify the direct spending on health care associated with brain disorders between 2000 and 2019.
-
Social prescribing in the USA: emerging learning and opportunities Lancet Public Health (IF 25.4) Pub Date : 2025-04-25 Rachel Marshall, Alexandra Bradbury, Nicole Morgan, Katrina Pineda, Daniel Hayes, Alexandra Burton, Jill Sonke, Daisy Fancourt
The global prevalence of chronic diseases and high costs of health care are complex challenges that are driving countries to focus on addressing the social determinants of health and downstream social needs. These challenges require innovative health-care practices that integrate disease prevention, treatment, and management with salutogenic initiatives to promote population health. Many countries
-
Health impact and economic evaluation of the Expanded Program on Immunization in China from 1974 to 2024: a modelling study Lancet Public Health (IF 25.4) Pub Date : 2025-04-23 Chaofan Wang, Xiaozhen Lai, Kaja Abbas, Koen B Pouwels, Haijun Zhang, Mark Jit, Hai Fang
BackgroundThe Expanded Program on Immunization (EPI), initiated by WHO in 1974, is a cornerstone of public health. China's EPI covers more than a sixth of the world's population and includes eight routine vaccines with high coverage rates. This study aimed to estimate health and economic impacts of China's EPI over the past 50 years (1974–2024). MethodsThis study mathematically modelled the impact
-
Comparing the effects of prescribed safer opioid supply and methadone in Ontario, Canada: a population-based matched cohort study Lancet Public Health (IF 25.4) Pub Date : 2025-04-22 Tara Gomes PhD, Daniel McCormack MSc, Gillian Kolla PhD, Samantha Young MD, Prof Ahmed M Bayoumi MD, Ashley Smoke, Ping Li PhD, Tony Antoniou PhD
Prescribed safer opioid supply (SOS) programmes are novel harm reduction interventions. We examined health outcomes among people receiving SOS over time and relative to a similar group of people receiving methadone.
-
Implementing public health policy to tackle alcohol-related harms Lancet Public Health (IF 25.4) Pub Date : 2025-04-10 Pojsakorn Danpanichkul, Karn Wijarnpreecha
The Global Burden of Disease Study 2021 identifies alcohol consumption as one of the top ten leading risk factors for disability.1 The COVID-19 pandemic has substantially affected public health, including shifts in alcohol-related mortality trends. Melissa Oldham and colleagues2 critically examine alcohol-specific deaths in England over the past two decades, revealing a sharp increase since 2020. The
-
Trends in alcohol-specific deaths in England, 2001–22: an observational study Lancet Public Health (IF 25.4) Pub Date : 2025-04-10 Melissa Oldham PhD, Sarah Jackson PhD, Prof Jamie Brown PhD, Vera Buss PhD, Gautam Mehta PhD, Prof Jennifer Beam Dowd PhD, Prof John Holmes PhD, Prof Colin Angus MSc
Following the COVID-19 pandemic, many countries saw large increases in rates of alcohol-specific deaths, including England. This study aimed to examine whether there have been changes in the characteristics of those dying by specific cause of death, age, sex, and area-level deprivation.
-
Effect of extending PrEP initiation to primary care settings: a nationwide cohort study in France Lancet Public Health (IF 25.4) Pub Date : 2025-04-09 Sophie Bamouni PhD, Sophie Billioti de Gage PhD, David Desplas MSc, Julie Valbousquet MSc, Julie Lamant MSc, Prof Jean-Philippe Joseph MD, Prof François Dabis MD, Agnès Viot MSc, Mojgan Hessamfar MD, Salim Fakir MSc, Rosemary Dray-Spira PhD, Prof Michel Carles MD
Pre-exposure prophylaxis (PrEP) medicines are key to reducing HIV infection. Improving access, increasing initiation, and expanding the populations covered is therefore important. In June, 2021, in France, PrEP initiation was extended to primary care. The aim of this study was to describe the deployment and characteristics of PrEP initiation in primary care.
-
Extending PrEP access and coverage in France Lancet Public Health (IF 25.4) Pub Date : 2025-04-09 Leslie Grammatico-Guillon, Yazdan Yazdanpanah
Pre-exposure prophylaxis (PrEP) has become a key strategy for HIV prevention worldwide.1, 2 Since 2016 in France, PrEP—in particular a fixed-dose combination of oral tenofovir disoproxil fumarate and emtricitabine—has been available and fully covered by the French Health Insurance for people considered at high-risk of HIV acquisition. Since its introduction, the number of PrEP initiations has steadily
-
Could people live longer and healthier? Lancet Public Health (IF 25.4) Pub Date : 2025-04-02 Qiushi Feng, Daisheng Tang
Japan is an important case in ageing research, showing how the epidemiological transition progresses in a society with almost 30% of its population older than 65 years. The latest Global Burden of Disease (GBD) Study 2021, published in The Lancet Public Health, traced a 30-year transformation of morbidity and mortality in Japan.1 The study suggests that Japan has seen a slowed or plateaued trend in
-
Effect of the COVID-19 pandemic on incarceration and tuberculosis Lancet Public Health (IF 25.4) Pub Date : 2025-03-31 Emma H Plugge, Nicola Cocco
Although preventable and curable, 10·8 million people were diagnosed with tuberculosis and 1·25 million people died from tuberculosis in 2023.1 It is a disease that disproportionately affects marginalised groups—for instance, it has been clearly shown that there is a high tuberculosis incidence and low case detection rate in prison populations globally.2 Indeed, WHO has identified incarcerated people
-
Effective interventions for active workplaces: time to get evidence into practice Lancet Public Health (IF 25.4) Pub Date : 2025-03-31 Elizabeth Goyder, Kelly Mackenzie
No Abstract
-
Health care universalism in Italy: a debunked myth Lancet Public Health (IF 25.4) Pub Date : 2025-03-31 Anna Odone, Riccardo Vecchio
Almost 50 years ago the Italian National Health Service (NHS) was established under the principles of health care universalism, equity, and solidarity. Where do we stand today? In an ageing society, where there is a struggle to balance increasing health needs with available resources to sustain health care, answering this question is imperative. In The Lancet Public Health, The Global Burden of Diseases
-
A new perspective on the health of people experiencing homelessness Lancet Public Health (IF 25.4) Pub Date : 2025-03-31 Maurizio Marceca, Giulia Civitelli, Serafina Torchiaro, Giuseppinanna Merlino, Salvatore Geraci
As noted by Di Simone and colleagues in their Correspondence,1 the change in Italian law introducing the right to public primary health care for people experiencing homelessness through registration with a general practitioner (GP) represents an important first step against inequities in health care.
-
Rates, causes, and risk factors for death among justice-involved young people in Australia: a retrospective, population-based data linkage study Lancet Public Health (IF 25.4) Pub Date : 2025-03-31 Stuart A Kinner, Lucas Calais-Ferreira, Jesse T Young, Rohan Borschmann, Alan Clough, Ed Heffernan, Scott Harden, Matthew J Spittal, Susan M Sawyer
BackgroundChildren and adolescents exposed to the youth justice system have poor health profiles, but little is known about their subsequent mortality. We aimed to examine mortality outcomes in a large, state-wide cohort of young people in Australia who had contact with the youth justice system. MethodsWe linked youth justice records in the state of Queensland, Australia from July 1, 1993, to June
-
Changes in incarceration and tuberculosis notifications from prisons during the COVID-19 pandemic in Europe and the Americas: a time-series analysis of national surveillance data Lancet Public Health (IF 25.4) Pub Date : 2025-03-31 Amy Zheng, Lena Faust, Anthony D Harries, Pedro Avedillo, Michael Akodu, Miranda Galvan, Beatriz Barreto-Duarte, Bruno B Andrade, César Ugarte-Gil, Alberto L Garcia-Basteiro, Marcos Espinal, Joshua L Warren, Leonardo Martinez
BackgroundThe COVID-19 pandemic disrupted tuberculosis control programmes globally; whether or not this disproportionately affected people who were incarcerated is unknown. We aimed to evaluate changes in incarceration and tuberculosis notifications in prisons in Europe and the Americas during the COVID-19 pandemic. MethodsData from WHO Pan American Health Organization (PAHO) and WHO Europe were used
-
Effects of workplace interventions on sedentary behaviour and physical activity: an umbrella review with meta-analyses and narrative synthesis Lancet Public Health (IF 25.4) Pub Date : 2025-03-31 Thomas Rouyard, Emilie Yoda, Katika Akksilp, Anna Valeria Dieterich, Sarin Kc, Saudamini V Dabak, Andre Matthias Müller
BackgroundPhysical inactivity is rising globally, exacerbating the burden of preventable deaths and diseases. Despite extensive research on promoting physical activity in the workplace, synthesising the existing literature is challenging due to the wide variety of interventions and outcomes. This study aims to provide a comprehensive synthesis of intervention effects to inform health promotion initiatives
-
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 Lancet Public Health (IF 25.4) Pub Date : 2025-03-31 Mohsen Naghavi
BackgroundOver the past two decades, the Italian National Health Service has been gradually decentralised, with Italy's 21 regional governments now responsible for managing their health services. This change, coupled with austerity measures and a steadily ageing population, has adversely affected universal health coverage and equity, exacerbating inequalities and regional disparities. This study aimed
-
Three decades of population health changes in Japan, 1990–2021: a subnational analysis for the Global Burden of Disease Study 2021 Lancet Public Health (IF 25.4) Pub Date : 2025-03-20 GBD 2021 Japan Collaborators, Shuhei Nomura, Michio Murakami, Santosh Kumar Rauniyar, Naoki Kondo, Takahiro Tabuchi, Haruka Sakamoto, Yasuharu Tokuda, Nishali Patel, Jose Navarro de Pablo, Joseph L Dieleman, Angela Y Chang, Vegard Skirbekk, Sarah K Abe, Norito Kawakami, Erika Ota, Scott D Glenn, Chimedsuren Ochir, Hiroaki Miyata, Manami Inoue, Kenji Shibuya, Isaac Yeboah Addo, Mohammed Ahmed Akkaif
Given Japan's rapidly ageing demographic structure, comprehensive and long-term evaluations of its national and subnational health progress are important to inform public health policy. This study aims to assess Japan's population health, using the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 to analyse the country's evolving disease patterns.
-
Public health under Trump 2.0: the first 50 days Lancet Public Health (IF 25.4) Pub Date : 2025-03-20 The Lancet Public Health
Jan 20, 2025, US President Donald Trump took charge of the Oval Office and began by signing an array of executive orders spanning from withdrawal from WHO and the Paris Climate Agreement to freezing trillions of US$ worth of federal funding and a ban on diversity, equity, and inclusion programmes. The new US Administration's onslaught on some of the world's most respected scientific public health institutions
-
Time to tackle obesogenic environments Lancet Public Health (IF 25.4) Pub Date : 2025-03-03
March 4th is World Obesity Day, a unified day of action calling for a response to the obesity crisis. Obesity is one of the most concerning public health crises globally. According to WHO, since 1990, obesity has more than doubled in adults and quadrupled in adolescents. In 2022, 2·5 billion adults had overweight, including 890 million with obesity, and 390 million children and adolescents aged 5–19
-
Cancer screening inequities and people with intellectual disabilities—what should we do to close the gaps? Lancet Public Health (IF 25.4) Pub Date : 2025-03-03 Hannah Kuper, Luthfi Azizatunnisa’
Evidence from electronic health records is transforming what we know about the health inequalities experienced by people with disabilities. In The Lancet Public Health, Amina Banda and colleagues produced another excellent example of this approach, using large-scale data from the Netherlands to demonstrate that participation in cancer screening programmes is around 20% lower for people with intellectual
-
Access to abortion in Canada Lancet Public Health (IF 25.4) Pub Date : 2025-03-03 Martha Jane Paynter
The study in The Lancet Public Health by Erin Brennand and colleagues1 looking at abortion care in Alberta, Canada, tests an optimistic hypothesis held by many, that the 2017 implementation and deregulation of mifepristone for medication abortion would substantially improve access to care. Until 2017, abortion in Canada was almost exclusively available through procedures carried out by physicians in
-
The responsibility of health: shifting the focus from individuals to systems Lancet Public Health (IF 25.4) Pub Date : 2025-03-03 Sandy Tubeuf, Alejandro Valdivia, Lara Tavoschi, Jean-Philippe Empana, Eivind Engebretsen
Social determinants of health, although widely acknowledged, tend to be poorly translated into policy. Health programme initiatives too often underline individual accountability, which reinforces a flawed narrative that overlooks structural barriers—poverty, inequitable access to resources, unsafe environments, and harmful commercial practices—which shape health behaviours.1
-
Cancer screening participation and outcomes among people with an intellectual disability in the Netherlands: a cross-sectional population-based study Lancet Public Health (IF 25.4) Pub Date : 2025-03-03 Amina Banda, Maarten Cuypers, Jenneken Naaldenberg, Aura Timen, Geraline Leusink
BackgroundPeople with an intellectual disability face diverse health disparities, including challenges accessing cancer care. In the Netherlands, as in many other countries, there are national screening programmes for early detection of breast, cervical, and colon cancer. These programmes were, however, initially introduced for the general population, and they often fail to meet the needs of the population
-
Abortion care in Alberta, Canada, from 2012 to 2023: a population-based, cross-sectional analysis of use and geographical access Lancet Public Health (IF 25.4) Pub Date : 2025-03-03 Erin A Brennand, Beili Huang, Natalie V Scime, Jadine Paw, Erin L Nelson
BackgroundEquitable access to abortion care remains a challenge in public health. Current Canadian abortion reporting overlooks modern practices such as mifepristone medication abortion and has no access and equity metrics. We aimed to comprehensively analyse abortion care provision in Alberta (the fourth largest province in Canada, home to more than 4 million people) focusing on temporal trends in
-
Public health in Germany: structures, dynamics, and ways forward Lancet Public Health (IF 25.4) Pub Date : 2025-03-03 Prof Hajo Zeeb MD, Prof Julika Loss PhD, Dagmar Starke PhD, Thomas Altgeld Dipl Psych, Prof Susanne Moebus PhD, Karin Geffert MD, Prof Ansgar Gerhardus MD
Despite Germany's robust economy, comprehensive social welfare system, and the country ranking third among Organisation for Economic Co-operation and Development countries in terms of per-capita health spending, its health indicators still lag behind those of other European nations. Germany also has one of the highest prevalences of major modifiable risk factors for non-communicable diseases within
-
Artificial intelligence in public health: promises, challenges, and an agenda for policy makers and public health institutions Lancet Public Health (IF 25.4) Pub Date : 2025-02-28 Dimitra Panteli DrPH, Keyrellous Adib MPH, Stefan Buttigieg MSc, Francisco Goiana-da-Silva PhD, Katharina Ladewig PhD, Natasha Azzopardi-Muscat PhD, Josep Figueras PhD, David Novillo-Ortiz PhD, Prof Martin McKee DSc
Artificial intelligence (AI) can rapidly analyse large and complex datasets, extract tailored recommendations, support decision making, and improve the efficiency of many tasks that involve the processing of data, text, or images. As such, AI has the potential to revolutionise public health practice and research, but accompanying challenges need to be addressed. AI can be used to support public health
-
Towards opioid access without excess Lancet Public Health (IF 25.4) Pub Date : 2025-02-26 William E Rosa PhD, Prof Felicia Marie Knaul PhD, Michael Touchton PhD, Afsan Bhadelia PhD, Prof Keith Humphreys PhD, Prof Lukas Radbruch MD, M R Rajagopal MD
A decade after World Health Assembly Resolution 67.19 recognised palliative care as a component of comprehensive care and universal health coverage throughout the life course, a balanced approach to opioid access remains elusive. Disparities in the alleviation of serious health-related suffering persist, characterised by two parallel opioid-related public health crises: a pandemic of unrelieved pain
-
Confronting the growing epidemic of silicosis and tuberculosis among small-scale miners Lancet Public Health (IF 25.4) Pub Date : 2025-02-25 Patrick Howlett MbChB, Bibie Said MD, Emmanuel Mwanga MSc, Alexander Mbuya MD, Manti Nota MSc, Prof Onn Min Kon MD, Perry Gottesfeld MPH, Johanna Feary PhD, Stellah Mpagama PhD, Prof Rodney Ehrlich FCPHM
An estimated 49·5 million small-scale miners worldwide are exposed to high concentrations of silica during their work. The substantial morbidity and mortality of silicosis and tuberculosis among workers exposed to such intensities have been documented. This Viewpoint raises concern at the failure to respond to a growing epidemic of lung disease (predominantly silicosis and tuberculosis) among small-scale
-
Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Lancet Public Health (IF 25.4) Pub Date : 2025-02-24 GBD Epilepsy Collaborators, Valery L Feigin, Theo Vos, Balakrishnan Sukumaran Nair, Simon I Hay, Yohannes Habtegiorgis Abate, Abdallah H A Abd Al Magied, Samar Abd ElHafeez, Atef Abdelkader, Mohammad-Amin Abdollahifar, Auwal Abdullahi, Richard Gyan Aboagye, Lucas Guimarães Abreu, Samir Abu Rumeileh, Hasan Abualruz, Salahdein Aburuz, Ahmed Abu-Zaid, Isaac Yeboah Addo, Rufus Adesoji Adedoyin, Abiola
Epilepsy is one of the most common serious neurological disorders and affects individuals of all ages across the globe. The aim of this study is to provide estimates of the epilepsy burden on the global, regional, and national levels for 1990–2021.
-
Global, regional, and national burden of suicide, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Lancet Public Health (IF 25.4) Pub Date : 2025-02-19 GBD 2021 Suicide Collaborators, Nicole Davis Weaver, Gregory J Bertolacci, Emily Rosenblad, Sama Ghoba, Matthew Cunningham, Kevin S Ikuta, Madeline E Moberg, Vincent Mougin, Chieh Han, Eve E Wool, Yohannes Habtegiorgis Abate, Habeeb Omoponle Adewuyi, Qorinah Estiningtyas Sakilah Adnani, Leticia Akua Adzigbli, Aanuoluwapo Adeyimika Afolabi, Suneth Buddhika Agampodi, Bright Opoku Ahinkorah, Aqeel Ahmad
Deaths from suicide are a tragic yet preventable cause of mortality. Quantifying the burden of suicide to understand its geographical distribution, temporal trends, and variation by age and sex is an essential step in suicide prevention. We aimed to present a comprehensive set of global, regional, and national estimates of suicide burden.
-
Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021 Lancet Public Health (IF 25.4) Pub Date : 2025-02-18 GBD 2021 Europe Life Expectancy Collaborators, Nicholas Steel, Clarissa Maria Mercedes Bauer-Staeb, John A Ford, Cristiana Abbafati, Mohammed Altigani Abdalla, Atef Abdelkader, Parsa Abdi, Roberto Ariel Abeldaño Zuñiga, Olugbenga Olusola Abiodun, Hassan Abolhassani, Eman Abu-Gharbieh, Hana J Abukhadijah, Ahmed Abu-Zaid, Isaac Yeboah Addo, Giovanni Addolorato, Victor Adekanmbi, Juliana Bunmi Adetunji
Decades of steady improvements in life expectancy in Europe slowed down from around 2011, well before the COVID-19 pandemic, for reasons which remain disputed. We aimed to assess how changes in risk factors and cause-specific death rates in different European countries related to changes in life expectancy in those countries before and during the COVID-19 pandemic.
-
Labels warning about alcohol-attributable cancer risks should be mandated urgently Lancet Public Health (IF 25.4) Pub Date : 2025-02-13 Carina Ferreira-Borges, Daša Kokole, Gauden Galea, Maria Neufeld, Jürgen Rehm
In January, 2025, the US Surgeon General released an Advisory on alcohol consumption and cancer risk.1 He briefly summarised the evidence on alcohol and cancer, including underlying biological mechanisms, and concluded that alcohol use is a leading preventable cause of cancer in the USA and globally, causing around 100 000 and 750 000 cancer cases annually, respectively.2 The carcinogenicity of alcohol
-
Correction to Lancet Public Health 2025; 10: e58–62 Lancet Public Health (IF 25.4) Pub Date : 2025-02-10
Friedman J, Ciccarone D. The public health risks of counterfeit pills. Lancet Public Health 2025; 10: e58–62—In this Viewpoint, the final sentence of the first paragraph of The possibility of a global synthetic drug crisis section should have read “to synthetic products such as methamphetamine and fentanyl”. This correction has been made as of Feb 10, 2025.
-
Tackling the growing burden of nitrous oxide-induced public health harms Lancet Public Health (IF 25.4) Pub Date : 2025-02-07 Safiya A Zaloum MBBS, Devan Mair MBBS, Alvar Paris MB BChir, Laura J Smith PhD, Marta Patyjewicz MD, Barbara L Onen MBChB, Prof Alastair J Noyce PhD
Nitrous oxide has been increasing in popularity as a recreational drug in the past decade, and with this an increase in health harms related to nitrous oxide use, particularly nitrous oxide-induced myeloneuropathy. In response, governments in many countries have adopted new laws that either target the end user, by criminalising possession, or target suppliers. The effect of these measures remains to
-
Life expectancy and mortality among males and females with HIV in British Columbia in 1996–2020: a population-based cohort study Lancet Public Health (IF 25.4) Pub Date : 2025-02-06 Katherine W Kooij PhD, Wendy Zhang MSc, Jason Trigg MA, Nance Cunningham MSc, Michael O Budu MD, Megan E Marziali MPH, Viviane Dias Lima PhD, Kate A Salters PhD, Rolando Barrios MD, Prof Julio S G Montaner MD, Prof Robert S Hogg PhD
Life expectancy of people with HIV has increased considerably. We used data from the Comparative Outcomes And Service Utilization Trends (COAST) study to examine sex differences in life expectancy and mortality between 1996 and 2020 among people with HIV in British Columbia (BC), Canada.
-
Italy strengthens health-care rights for homeless people Lancet Public Health (IF 25.4) Pub Date : 2025-02-05 Emanuele Di Simone, Erika Renzi, Fabio Fabbian, Nicolò Panattoni, Azzurra Massimi
People who are homeless or face uncertain housing and economic situations encounter substantial challenges in managing acute and chronic diseases, as poor living conditions can worsen health outcomes. Health status depends on the conditions in which people are born, live, and age, and monitoring social determinants of health is essential in addressing health inequities, especially in supporting socially
-
Mass incarceration as a key driver of gender disparities in tuberculosis Lancet Public Health (IF 25.4) Pub Date : 2025-02-05 Katherine C Horton, S Bertel Squire
We read with interest the article by Yiran Liu and colleagues assessing the contribution of mass incarceration to tuberculosis incidence in six Latin American countries.1 We welcome the attention that the authors bring to this important determinant of tuberculosis, yet we note that the authors do not mention the gendered dimension of this issue.
-
Correction to Lancet Public Health 2025; 10: e136–47 Lancet Public Health (IF 25.4) Pub Date : 2025-02-04
Global Burden of Disease US Health Disparities Collaborators. Life expectancy by county and educational attainment in the USA, 2000–19: an observational analysis. Lancet Public Health 2025; 10: e136–47—In this Article, the last sentence of the Summary, Findings should read “Over the study period, the gap in life expectancy between the college graduate population and those with less than a high-school
-
Cancer screening: putting people at the centre Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 The Lancet Public Health
Feb 4 marks World Cancer Day—an opportunity to raise awareness about cancer and to reflect on the latest trends, challenges, and hopes. Acknowledging that cancer is not simply a medical diagnosis, but rather a unique personal story, the World Cancer Day campaign places people at the centre and calls for a people-centred approach to cancer.
-
Family-wide effects of adverse childhood experiences Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 Nicole Racine, Shainur Premji
Exposure to adverse childhood experiences (ACEs), including abuse, neglect, and household challenges, have harmful implications for long-term health and mental health outcomes.1 Indeed, ACEs are one of the leading determinants of mental health disorders and are associated with increased health-care use into adulthood.1, 2 ACEs have the potential to infiltrate the family context, having implications
-
Does everyone benefit equally from physical activity? Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 Mats Börjesson, Daniel Arvidsson
Regular physical activity is associated with a lower risk of cardiovascular disease and cancer, and with longevity.1 Studies on physical activity and health have initially been based on observational studies with small sample sizes.2 Nowadays, the study quality has improved and includes laboratory-based studies with controlled interventions, albeit with limited external validity, as well as longitudinal
-
Thank you to The Lancet Public Health's reviewers in 2024 Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 The Lancet Public Health Editors
No Abstract
-
Reflections on the tobacco-free generation: methodological challenges and global implications Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 A Sathiya Susuman
The study by Julia Rey Brandariz and colleagues1 provides a novel approach to estimating the effect of a tobacco-elimination strategy on lung-cancer mortality by projecting outcomes for a cohort born between 2006 and 2010 across 185 countries. Although this simulation study offers promising results, with the potential to prevent more than 40% of deaths from lung cancer in the cohort, several issues
-
Reflections on the tobacco-free generation: methodological challenges and global implications Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 Sergi Trias-Llimós, Ariadna Feliu, Esteve Fernández
No Abstract
-
Reflections on the tobacco-free generation: methodological challenges and global implications – Authors’ reply Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 Julia Rey Brandariz, Mónica Pérez-Ríos, Alberto Ruano-Ravina, Isabelle Soerjomataram
No Abstract
-
Correction to Lancet Public Health 2024; 9: e684–99 Lancet Public Health (IF 25.4) Pub Date : 2025-02-03
Macdonald C, Macpherson G, Leppan O, et al. Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis. Lancet Public Health 2024; 9: e684–99—In the Findings section of the Summary of this Article, the 95% CI in the second sentence should read “Therapeutic community interventions reduced re-arrest at 6–12 months (six studies; odds
-
Acceptability and perceptions of personalised risk-based cancer screening among health-care professionals and the general public: a systematic review and meta-analysis Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 Naomi Q P Tan PhD, Renu S Nargund MSc, Elisa E Douglas PhD, Maria A Lopez-Olivo MD PhD, Paul J Resong BS, Sayaka Ishizawa PhD, Sara Nofal MD PhD, Kate Krause MS, Prof Robert J Volk PhD, Iakovos Toumazis PhD
Personalised risk-based screening (PRBS) can enhance the efficiency of cancer screening programnes, but little is known about support for its implementation among the general public and health-care professionals. We aimed to summarise the acceptability and perceptions of PRBS for breast, cervical, colorectal, lung, and prostate cancer screening among these groups.